Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Here’s What Happened

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY) gapped down prior to trading on Wednesday . The stock had previously closed at $9.72, but opened at $9.24. Sysmex shares last traded at $9.62, with a volume of 44,221 shares trading hands.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. The Goldman Sachs Group upgraded shares of Sysmex from a “hold” rating to a “buy” rating in a research note on Thursday, October 9th. Zacks Research upgraded shares of Sysmex from a “strong sell” rating to a “hold” rating in a research report on Thursday, August 14th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy”.

Sysmex Stock Performance

The stock has a market cap of $6.05 billion, a price-to-earnings ratio of 19.21 and a beta of 1.16. The company has a quick ratio of 2.49, a current ratio of 3.37 and a debt-to-equity ratio of 0.12. The company has a 50 day simple moving average of $11.77 and a 200 day simple moving average of $14.51.

Sysmex (OTCMKTS:SSMXY) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.16 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.16. The company had revenue of $826.60 million for the quarter, compared to the consensus estimate of $880.80 million. Sysmex had a net margin of 9.35% and a return on equity of 10.20%. As a group, equities research analysts forecast that Sysmex Corporation ADR will post 0.57 EPS for the current year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.